A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
Keyword(s):
Keyword(s):
1999 ◽
Vol 19
(3)
◽
pp. 253-259
◽
Keyword(s):
Keyword(s):
2011 ◽
Vol 142
(5)
◽
pp. 1143-1151
◽
Keyword(s):
2014 ◽
Vol 90
(1)
◽
pp. S146-S147
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 8039-8039
◽
Keyword(s):
Keyword(s):
Keyword(s):